BioSpace News Archive

Progenity, Inc., an innovative biotechnology company, announced that the company will participate in a pre-recorded fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, which will be available on the conference website beginning at 10 a.m. Eastern / 7 a.m. Pacific on November 22, 2021.

Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that it has entered into a multi-year agreement with Tolmar Pharmaceuticals, Inc. to co-promote ALKINDI SPRINKLE®.

Osmotica Pharmaceuticals plc announced today that Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will present at the Jefferies London Virtual Healthcare Conference 2021 as follows: Date: Thursday, November 18, 2021

Leuven, BE, Boston, MA, US – 15 November 2021 – 07.00 AM CET – Oxurion NV, a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, announces the first patient has been dosed in Part B of its two-part, Phase 2 study evaluating multiple injections of THR-149 for the treatment of DME.

The protein detection and qualification market has been anticipated to grow at a significant speed in the forthcoming years.

The patient registry software market is anticipated to experience noteworthy growth avenues in the upcoming years.

Transparency Market Research has published a new report titled, ‘Extracorporeal Membrane Oxygenation Machine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to Transparency Market Research, the global endometrial ablation market is foreseen to exhibit a steady CAGR of 5.50% within the forecast period from 2016 to 2024.

Biosimilars can be defined as a biologic medical product, which is considered to be similar to already approved biologic.

Valbiotis, a Research and Development company committed to scientific innovation for preventing and combating metabolic diseases, announces the selection of TOTUM•070’s positive preclinical results in hypercholesterolemia by the annual meeting of the American Heart Association, the leading American learned society in the cardiovascular field.